Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

912 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Understanding surgical interventions in RCTs: the need for better methodology.
Avery KN, Barham CP, Berrisford R, Blazeby JM, Blencowe NS, Donovan J, Elliott J, Falk SJ, Goldin R, Hanna G, Hollowood AD, Metcalfe C, Noble S, Sanders G, Streets CG, Titcomb DR, Wheatley T. Avery KN, et al. Among authors: noble s. Lancet. 2013 Jan 5;381(9860):27-8. doi: 10.1016/S0140-6736(13)60015-X. Lancet. 2013. PMID: 23290962 No abstract available.
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a randomised, single-blind, non-inferiority trial.
Pilgrim T, Heg D, Roffi M, Tüller D, Muller O, Vuilliomenet A, Cook S, Weilenmann D, Kaiser C, Jamshidi P, Fahrni T, Moschovitis A, Noble S, Eberli FR, Wenaweser P, Jüni P, Windecker S. Pilgrim T, et al. Among authors: noble s. Lancet. 2014 Dec 13;384(9960):2111-22. doi: 10.1016/S0140-6736(14)61038-2. Epub 2014 Sep 1. Lancet. 2014. PMID: 25189359 Clinical Trial.
Long-Term Effect of Ultrathin-Strut Versus Thin-Strut Drug-Eluting Stents in Patients With Small Vessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Subgroup Analysis of the BIOSCIENCE Randomized Trial.
Iglesias JF, Heg D, Roffi M, Tüller D, Noble S, Muller O, Moarof I, Cook S, Weilenmann D, Kaiser C, Cuculi F, Häner J, Jüni P, Windecker S, Pilgrim T. Iglesias JF, et al. Among authors: noble s. Circ Cardiovasc Interv. 2019 Aug;12(8):e008024. doi: 10.1161/CIRCINTERVENTIONS.119.008024. Epub 2019 Aug 6. Circ Cardiovasc Interv. 2019. PMID: 31525083 Clinical Trial.
Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
Räber L, Taniwaki M, Zaugg S, Kelbæk H, Roffi M, Holmvang L, Noble S, Pedrazzini G, Moschovitis A, Lüscher TF, Matter CM, Serruys PW, Jüni P, Garcia-Garcia HM, Windecker S; IBIS 4 (Integrated Biomarkers and Imaging Study-4) Trial Investigators (NCT00962416). Räber L, et al. Among authors: noble s. Eur Heart J. 2015 Feb 21;36(8):490-500. doi: 10.1093/eurheartj/ehu373. Epub 2014 Sep 2. Eur Heart J. 2015. PMID: 25182248 Free article. Clinical Trial.
Long-term safety and feasibility of three-vessel multimodality intravascular imaging in patients with ST-elevation myocardial infarction: the IBIS-4 (integrated biomarker and imaging study) substudy.
Taniwaki M, Radu MD, Garcia-Garcia HM, Heg D, Kelbæk H, Holmvang L, Moschovitis A, Noble S, Pedrazzini G, Saunamäki K, Dijkstra J, Landmesser U, Wenaweser P, Meier B, Stefanini GG, Roffi M, Lüscher TF, Windecker S, Räber L. Taniwaki M, et al. Among authors: noble s. Int J Cardiovasc Imaging. 2015 Jun;31(5):915-26. doi: 10.1007/s10554-015-0631-0. Epub 2015 Feb 28. Int J Cardiovasc Imaging. 2015. PMID: 25721728
Circadian dependence of manual thrombus aspiration benefit in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Fournier S, Muller O, Benedetto U, Roffi M, Pilgrim T, Eberli FR, Rickli H, Radovanovic D, Erne P, Cook S, Noble S, Fesselet R, Zuffi A, Degrauwe S, Masci P, Windecker S, Eeckhout E, Iglesias JF; on behalf on the AMIS Plus Investigators. Fournier S, et al. Among authors: noble s. Clin Res Cardiol. 2018 Apr;107(4):338-346. doi: 10.1007/s00392-017-1189-8. Epub 2017 Dec 8. Clin Res Cardiol. 2018. PMID: 29222592 Free article.
Age-Related Outcomes After Transcatheter Aortic Valve Replacement: Insights From the SwissTAVI Registry.
Attinger-Toller A, Ferrari E, Tueller D, Templin C, Muller O, Nietlispach F, Toggweiler S, Noble S, Roffi M, Jeger R, Huber C, Carrel T, Pilgrim T, Wenaweser P, Togni M, Cook S, Heg D, Windecker S, Goy JJ, Stortecky S. Attinger-Toller A, et al. Among authors: noble s. JACC Cardiovasc Interv. 2021 May 10;14(9):952-960. doi: 10.1016/j.jcin.2021.01.042. Epub 2021 Apr 14. JACC Cardiovasc Interv. 2021. PMID: 33865734 Free article.
Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry.
Wenaweser P, Stortecky S, Heg D, Tueller D, Nietlispach F, Falk V, Pedrazzini G, Jeger R, Reuthebuch O, Carrel T, Räber L, Amann FW, Ferrari E, Toggweiler S, Noble S, Roffi M, Gruenenfelder J, Jüni P, Windecker S, Huber C. Wenaweser P, et al. Among authors: noble s. EuroIntervention. 2014 Dec;10(8):982-9. doi: 10.4244/EIJV10I8A166. EuroIntervention. 2014. PMID: 24694729 Free article.
912 results